Using a new electronic tool to assess symptoms in head and neck cancer patients
Official title: Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
Funded at University of Texas Hlth Sci Ctr Houston · NIH-10931436 · Data updated 2026-11-12
This study is testing a new tool that helps doctors check in on head and neck cancer patients' symptoms in real-time, so they can provide better care and support, and it includes people from both rural and urban areas to make sure everyone can benefit.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $644,318 |
| NIH project number | 5R01CA282149-02 |
| Project ID | NIH-10931436 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with head and neck cancer who are undergoing treatment.
✕Less likely to help
Patients with head and neck cancer who are not receiving treatment or those with advanced disease may not benefit from this research.
What this research studies
This research focuses on implementing the NYU Electronic Patient Visit Assessment (ePVA) to improve symptom management for patients diagnosed with head and neck cancer. The ePVA is designed to capture patient-reported symptoms in real-time, allowing healthcare providers to intervene promptly and effectively. By integrating this tool with electronic health records, the research aims to enhance the detection of symptoms that often go unnoticed, ultimately improving patient quality of life and reducing the need for acute care. The study will involve both rural and urban populations to ensure diverse representation and access to this innovative approach.
Why it matters
Potential benefit: If successful, this research could lead to better symptom management and improved quality of life for head and neck cancer patients.
How similar studies have gone: Previous research has shown that patient-reported symptom monitoring can significantly improve cancer care outcomes, indicating a promising potential for this approach.
Where this research is happening
-
University of Texas Hlth Sci Ctr Houston
Houston, United States Active
Researchers
- Principal investigator: Van Cleave, Janet H — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Van Cleave, Janet H
Related research
Other NIH-funded projects on the same topics.
-
Combined Imaging and RNA Markers to Predict Head and Neck Cancer Recurrence
A research project aims to use imaging and RNA data to better predict if head and neck cancer will come back, helping doctors tailor treatments for patients.
-
Biomarker to guide treatment in head and neck cancer
A biomarker test using tumor samples is being developed to predict recurrence risk in oral cancers and help tailor treatment.
-
Intensive dental care during cancer follow-up to protect teeth after head and neck radiation
A program delivered in oncology clinics to provide fluoride varnish and dental follow-up aims to reduce tooth decay and improve oral health and quality of life for head and neck cancer patients after radiation therapy.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A computer program helps plan radiation therapy for cervical and head-and-neck cancer patients to make treatments faster and more accurate.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A United Kingdom study is testing AI software that helps plan radiotherapy for cervical and head-and-neck cancer patients to save time and reduce the workload for clinicians in low-resource settings.
-
AI-powered radiotherapy planning for cervical and head-and-neck cancer
A UK research team is testing an AI-based software to automatically outline cancer areas and plan radiation beams to speed up treatment for cervical and head-and-neck cancers in LMICs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.